Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

Social

Feb 7, 2025

NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20

HANGZHOU,China,Feb. 6,2025-- NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase" or the "Company"),a leading internet and game services provider,today announced that it will report

Social

Feb 7, 2025

Yum China Reports Fourth Quarter Results and Increases Dividend by 50%

Fourth Quarter Operating Profit Grew 36% and OP Margin1 Expanded 140 Basis Points Sequential Improvement in Same-Store Sales Index and Eighth Consecutive Quarter of Same-Store Transaction Growth

Social

Feb 7, 2025

KT&G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns

New CEO\'s fundamental competitiveness improvement and financial structure optimization leads to parallel growth of full-year revenue and operating profit

Social

Feb 7, 2025

Personetics' New Features Give Banks More Ways to Monetize Customer Wellness

Personetics\' latest product release empowers financial institutions to develop highly personalized customer experiences that democratize financial advice,inspire action,and drive business value

Social

Feb 7, 2025

Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study)

"Revolutionary portable device leverages advanced magnetic resonancetechnology to rapidly detect acute stroke biomarkers,enabling frontline care teams to make faster,life-saving decisions within

Social

Feb 7, 2025

Social

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20

Yum China Reports Fourth Quarter Results and Increases Dividend by 50%

KT&amp;G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns

Personetics&#039; New Features Give Banks More Ways to Monetize Customer Wellness

Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for &#039;Axana&#039; 0.1T portable magnetic resonance imaging device (Portable MRI study)

KT&G Successfully Improves Profitability in First Year of New Leadership, Promises Active Shareholder Returns

Personetics' New Features Give Banks More Ways to Monetize Customer Wellness

Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study)